Ruthenium (Ru) complex conjugates drugs and targeted tumors by inhibiting oral cancer cells

Ruthenium (Ru) complex conjugates drugs and targeted tumors by inhibiting oral cancer cells

Saved in:

Bibliographic Details
Main Author:	Rethinam Senthil
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024002139
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reduced-graphene oxide (R-GO) conjugated methotrexate (MTX) killing of oral cancer cells
by: Rethinam Senthil
Published: (2024-06-01)

Inhibitory potential against oral squamous cancer cells demonstrated by amyloid beta peptide (s)/doxorubicin (DOX) conjugates
by: Rethinam Senthil
Published: (2024-06-01)

Helping anti-cancer activity of cetuximab (Erbitux) by monoclonal antibody conjugated nanocurcumin - In vitro studies on human oral squamous carcinoma cell line (OECM)
by: Rethinam Senthil, et al.
Published: (2024-03-01)

Inhibition of cancer cells using target-specific 2A3 antibody-conjugated gold nanoclusters
by: Jui-Chi Kuo, et al.
Published: (2022-03-01)

Assessment of targets of antibody drug conjugates in SCLC
by: Abhishek Ajay, et al.
Published: (2025-01-01)

Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01)

Anticancer effect of the antirheumatic drug leflunomide on oral squamous cell carcinoma by the inhibition of tumor angiogenesis
by: Chieko Niwata, et al.
Published: (2025-01-01)

Peptide Aptamer–Paclitaxel Conjugates for Tumor Targeted Therapy
by: Xinyang Shen, et al.
Published: (2024-12-01)

Impact of HER2-targeting antibody drug conjugates in treatment strategies for patients with breast cancer
by: Hanghang Ma, et al.
Published: (2025-02-01)

Study of Ruthenium Complex Sensitizer and Gold Nanoparticles Doped Flexible Organic Solar Cells
by: Cheng-Chiang Chen, et al.
Published: (2012-01-01)

Ruthenium(II) Complex with 1-Hydroxy-9,10-Anthraquinone Inhibits Cell Cycle Progression at G0/G1 and Induces Apoptosis in Melanoma Cells
by: Júlia S. M. Dias, et al.
Published: (2025-01-01)

EGFR-targeting RNase A-cetuximab antibody-drug conjugate induces ROS-mediated apoptosis to overcome drug resistance in KRAS mutant cancer cells
by: Bita Jafary, et al.
Published: (2025-01-01)

Synthesis and Study of the Physical and Photovoltaic Properties of Novel Heteroleptic Ruthenium(II) Complexes Ligated with Highly π-Conjugated Bipyridine Ancillary and Phenanthroline Anchoring Ligand for Dye-Sensitized Solar Cells
by: Hyejeong Lee, et al.
Published: (2021-01-01)

A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer
by: Xue Zheng, et al.
Published: (2025-01-01)

Dye-Sensitized Nanocrystalline ZnO Solar Cells Based on Ruthenium(II) Phendione Complexes
by: Hashem Shahroosvand, et al.
Published: (2011-01-01)

Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism
by: Bartlomiej Taciak, et al.
Published: (2025-02-01)

A bispecific antibody-drug conjugate targeting pCAD and CDH17 has antitumor activity and improved tumor-specificity
by: Alyssa Synan, et al.
Published: (2025-12-01)

RGD-Human Serum Albumin Conjugates as Efficient Tumor Targeting Probes
by: Kai Chen, et al.
Published: (2009-03-01)

Impacts of genomic alterations on the efficacy of HER2-targeted antibody–drug conjugates in patients with metastatic breast cancer
by: Riqing Huang, et al.
Published: (2025-01-01)

Hydrogen production via dehydrogenation of alcohols using ruthenium hexamethylenetetramine complex
by: Preeti Devi, et al.
Published: (2024-08-01)

Targeting Ribosome Biogenesis for Cancer Therapy with Oral Platinum Complexes
by: Dongfan Song, et al.
Published: (2024-12-01)

Ruthenium Sensitizers and Their Applications in Dye-Sensitized Solar Cells
by: Yuancheng Qin, et al.
Published: (2012-01-01)

Therapeutic Effect of Cu(II) Complex with Photocatalytic Property on Gastric Cancer by Inhibiting the Proliferation of Tumor Cells
by: Dan Yu, et al.
Published: (2022-01-01)

SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF RUTHENIUM NITROSYL COMPLEXES CONTAINING POLYPYRIDYL LIGANDS
by: Dayana P. S. Penha, et al.
Published: (2025-02-01)

Advancements in targeted drug delivery: A promising approach in oral cancer treatment
by: Rajkumar Prabhakaran, et al.
Published: (2024-06-01)

Engineering hydrophobicity and manufacturability for optimized biparatopic antibody–drug conjugates targeting c-MET
by: Andreas Evers, et al.
Published: (2024-12-01)

Targeted SPP1 Inhibition of Tumor‐Associated Myeloid Cells Effectively Decreases Tumor Sizes
by: Benan Kartal, et al.
Published: (2025-01-01)

Silver-Ruthenium Dioxide Contacts
by: D. J. Pedder
Published: (1976-01-01)

Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
by: Matteo Perra, et al.
Published: (2025-01-01)

Studies of the Antiproliferative Activity of Ruthenium (II) Cyclopentadienyl-Derived Complexes with Nitrogen Coordinated Ligands
by: Virtudes Moreno, et al.
Published: (2010-01-01)

The development and evaluation of a tublysine-based antibody-drug conjugate with enhanced tumor therapeutic efficacy
by: Huihui Guo, et al.
Published: (2025-02-01)

Targeted therapy: Role of liposome-based drug delivery in advancing oral cancer treatment
by: Meenakshi Sundari Rajendran, et al.
Published: (2024-06-01)

Eupalinolide B inhibits periodontitis development by targeting ubiquitin conjugating enzyme UBE2D3
by: Wenhua Kuang, et al.
Published: (2025-01-01)

Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines
by: Kyle K. L. Phua
Published: (2015-01-01)

Synthesis and Application of New Ruthenium Complexes Containing β-Diketonato Ligands as Sensitizers for Nanocrystalline TiO2 Solar Cells
by: Ashraful Islam, et al.
Published: (2011-01-01)

Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
by: Guang-zhao Huang, et al.
Published: (2021-01-01)

Investigation of photophysical properties and potential biological applications of substituted tris(polypyridyl)ruthenium(II) complexes
by: T. Sumitha Celin, et al.
Published: (2025-02-01)

Emerging targeted therapies in oral oncology: Focus on EGFR inhibition
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-09-01)

Crystal structure of chlorido-(η6-toluene)(2,2′-bipyridine-κ2N,N′)ruthenium(II) hexafluorophosphate, C17H16ClN2RuPF6
by: Gichumbi Joel M., et al.
Published: (2022-08-01)

Crystal Structure of Ruthenium Phthalocyanine with Diaxial Monoatomic Ligand: Bis(Triphenylphosphine)Iminium Dichloro(Phthalocyaninato(2-))Ruthenium(III)
by: Derrick Ethelbhert Yu, et al.
Published: (2013-01-01)